3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Breast Neoplasms
8
Neoplasms
4
Multiple Myeloma
3
Radiation Injuries
2
Multiple Chronic Conditions
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Esophageal Neoplasms
2
Cognitive Dysfunction
2
Brain Neoplasms
2
Substance-Related Disorders
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Pain
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Mobility Limitation
1
Melanoma
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Kidney Neoplasms
1
Hyperthermia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Cyclophosphamide
117
Rituximab
115
fludarabine phosphate
79
Peripheral Blood Stem Cell Transplantation
71
Mycophenolic Acid
55
Whole-Body Irradiation
52
Filgrastim
49
Tacrolimus
43
Cyclosporine
43
Radiotherapy
41
Busulfan
41
Antilymphocyte Serum
38
Etoposide
36
Melphalan
34
Lenalidomide
31
Methotrexate
25
fludarabine
23
Cord Blood Stem Cell Transplantation
22
Bortezomib
20
Flow Cytometry
19
Cytarabine
19
Methylprednisolone
18
Bendamustine Hydrochloride
18
obinutuzumab
17
Prednisone
15
Granulocyte Colony-Stimulating Factor
15
Carmustine
15
sargramostim
14
orelabrutinib
14
Therapeutics
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, B-Cell, Marginal Zone
×
Patient Reported Outcome Measures
×
Clear all
NCT07558057
2026-04-30
COGNITOX
University of Aarhus
Not yet recruiting
225 enrolled